FRANKFURT (dpa-AFX Broker) - Gerresheimer shares led the MDax on Wednesday in an indecisive market environment. The shares of the specialist for specialty packaging gained 2.8 percent to 100.30 euros and thus returned to the simple 200-day line. The day before, they had only just defended the exponentially calculated variant of the average line.

The growth path has never been so crystal clear, wrote analyst Ed Hall from investment house Stifel in his current recommendation. His target price of 130 euros is above the record high of almost 123 euros reached last September. Hall is focusing in particular on the enormous opportunities offered by the weight loss injection with the hormone GLP-1, for which the Düsseldorf-based company supplies syringes, pens and autoinjectors./ag/stk

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------